[1] Specht L, Dabaja B, Illidge T, et al. Modern radiation therapy for primary cutaneous lymphomas:field and dose guidelines from the International Lymphoma Radiation Oncology Group[J]. Int J Radiat Oncol Biol Phys, 2015, 92(1):32-39. [2] Specht L, Yahalom J, Illidge T, et al. Modern radiation therapy for Hodgkin lymphoma:field and dose guidelines from the international lymphoma radiation oncology group (ILROG)[J]. Int J Radiat Oncol Biol Phys, 2014, 89(4):854-862. [3] Efferth T. Willmar Schwabe Award 2006:antiplasmodial and antitumor activity of artemisinin——from bench to bedside[J]. Planta Med, 2007, 73(4):299-309. [4] Luo J, Zhu W, Tang Y, et al. Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo[J]. Radiat Oncol, 2014, 9:84. [5] Yamachika E, Habte T, Oda D. Artemisinin:an alternative treatment for oral squamous cell carcinoma[J]. Anticancer Res, 2004, 24(4):2153-2160. [6] Button RW, Lin F, Ercolano E, et al. Artesunate induces necrotic cell death in schwannoma cells[J]. Cell Death Dis, 2014, 5:e1466. [7] Kim BM, Chung HW. Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes[J]. Biochem Biophys Res Commun, 2007, 363(3):745-750. [8] Putcha GV, Harris CA, Moulder KL, et al. Intrinsic and extrinsic pathway signaling during neuronal apoptosis:lessons from the analysis of mutant mice. J Cell Biol, 2002, 157(3):441-453. [9] Tait SW, Green DR. Mitochondria and cell death:outer membrane permeabilization and beyond[J]. Nat Rev Mol Cell Biol, 2010, 11(9):621-632. [10] Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms:a radical therapeutic approach[J]. Nat Rev Drug Discov, 2009, 8(7):579-591. [11] Hamacher-Brady A, Stein HA, Turschner S, et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production[J]. J Biol Chem, 2011, 286(8):6587-6601. [12] 曹延萍, 王莎, 刘杰, 等. 线粒体凋亡途径在高糖刺激的小鼠足细胞凋亡中的作用[J]. 中国应用生理学杂志, 2013, 29(3):244-246. [13] Scarfo L, Ghia P. Reprogramming cell death:BCL2 family inhibition in hematological malignancies[J]. Immunol Lett, 2013, 155(1-2):36-39. [14] Fani S, Kamalidehghan B, Lo KM, et al. Anticancer activity of a monobenzyltin complex C1 against MDA-MB-231 cells through induction of apoptosis and inhibition of breast cancer stem cells[J]. Sci Rep, 2016, 6:38992. [15] Chen Q, Chen L, Wu X, et al. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway[J]. IUBMB Life, 2016, 68(3):220-231. [16] 李秀娟, 李玉珍, 金春婷, 等. 姜黄素作用PTEN/P13K/AKT通路诱导食管癌ECl09细胞凋亡[J]. 中国应用生理学杂志, 2015, 31(2):174-177. |